PERJETA J Code: J9306

Drug & Product Overview

HCPCS Descriptor Injection, pertuzumab, 1 mg

HCPCS Added Date January 1, 2014

Manufacturer Genentech

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution, Concentrate

About PERJETA

Perjeta is a medication aligned to the HCPCS J Code: J9306 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by Genentech.

According to CMS Drug Use Information: Pertuzumab is used to treat breast cancer. Pertuzumab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
50242-0145-01	Perjeta	Genentech, Inc.	420	420 MG / 14 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

PERJETA Pricing & Reimbursement

J9306 Private Payer Reimbursement

$17.64 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

PERJETA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 11.72%

Avg. Days to File 9.2days

Avg. Days to Pay 24.8days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9306 claims analytics on FocalPoint →

PERJETA CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Perjeta (J9306) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

PERJETA Medically Unlikely Edits (MUE)

The most billing units of J9306 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

840 units / day

= 840 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

PERJETA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Early Breast Cancer Metastatic Breast Cancer

Drug Class

HER2/Neu/cerbB2 Antagonists [MoA]HER2/neu Receptor Antagonist [EPC]

Frequently Asked Questions

Is there an available Perjeta billing and coding guide?

Billing and coding information for PERJETA can be found through Genentech. Visit Here →

Are there any available Perjeta patient assistance programs?

PERJETA patient assistance information can be found through Genentech. Visit Here →

Where can I find Perjeta prescribing information?

PERJETA prescribing information can be found at the link below: Visit Here →

Where can I find Perjeta side effect information?

Information regarding PERJETA's side effects can be found at MedlinePlus Visit Here →

Does billing PERJETA require JZ/JW wastage modifiers?

CMS has identified PERJETA(J9306) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.